Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (1041-1050 of 1,298) with videos related to

Pageof 130
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|October 7, 2015
Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Premenopausal WomenCarol J Fabian, Bruce F Kimler, Teresa A Phillips, et al.
Cancer Treatment and Research|January 5, 2002
Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancerGordon B Mills, Astrid Eder, Xianjun Fang, et al.
American Journal of Human Genetics|February 21, 2012
Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in manKarin Tuschl, Peter T Clayton, Sidney M Gospe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2018
Precision Oncology Decision Support: Current Approaches and Strategies for the FutureKatherine C Kurnit, Ecaterina E Ileana Dumbrava, Beate Litzenburger, et al.
Cancer Cell|March 14, 2018
BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination DeficiencyChaoyang Sun, Jun Yin, Yong Fang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancerYinghui Guan, Wen-Lin Kuo, Jackie L Stilwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agentsMuling Mao, Feng Tian, John M Mariadason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2018
<i>PIK3CA</i> Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial CarcinomaFrederik Holst, Henrica M J Werner, Siv Mjøs, et al.
Cancer Cell|March 16, 2017
Integrated Molecular Characterization of Uterine CarcinosarcomaAndrew D Cherniack, Hui Shen, Vonn Walter, et al.
Journal of the National Cancer Institute|June 6, 2002
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRODavid M Euhus, Kristin C Smith, Linda Robinson, et al.
Pageof 130

Showing results (1041-1050 of 1,298) with videos related to

Sort By:
Pageof 130
Cancer Prevention Research (Philadelphia, Pa.)|October 7, 2015
Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Premenopausal WomenCarol J Fabian, Bruce F Kimler, Teresa A Phillips, et al.
Cancer Treatment and Research|January 5, 2002
Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancerGordon B Mills, Astrid Eder, Xianjun Fang, et al.
American Journal of Human Genetics|February 21, 2012
Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in manKarin Tuschl, Peter T Clayton, Sidney M Gospe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2018
Precision Oncology Decision Support: Current Approaches and Strategies for the FutureKatherine C Kurnit, Ecaterina E Ileana Dumbrava, Beate Litzenburger, et al.
Cancer Cell|March 14, 2018
BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination DeficiencyChaoyang Sun, Jun Yin, Yong Fang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancerYinghui Guan, Wen-Lin Kuo, Jackie L Stilwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agentsMuling Mao, Feng Tian, John M Mariadason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2018
<i>PIK3CA</i> Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial CarcinomaFrederik Holst, Henrica M J Werner, Siv Mjøs, et al.
Cancer Cell|March 16, 2017
Integrated Molecular Characterization of Uterine CarcinosarcomaAndrew D Cherniack, Hui Shen, Vonn Walter, et al.
Journal of the National Cancer Institute|June 6, 2002
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRODavid M Euhus, Kristin C Smith, Linda Robinson, et al.
Pageof 130